← Back to headlines
Novo Nordisk Experiences Worst Monthly Decline as Eli Lilly Extends Lead
Novo Nordisk has recorded its worst monthly decline, while competitor Eli Lilly has extended its market lead, indicating a shift in the pharmaceutical market.
28 Feb, 16:19 — 28 Feb, 16:19
ℹOnly 1 source covers this story
